Aurisco Pharmaceutical Co.,Ltd.

XSSC:605116 Stock Report

Market Cap: CN¥8.6b

Aurisco PharmaceuticalLtd Management

Management criteria checks 2/4

Aurisco PharmaceuticalLtd's CEO is Dingjun Chu, appointed in Jun 2017, has a tenure of 7.42 years. directly owns 0.81% of the company’s shares, worth CN¥69.72M. The average tenure of the management team and the board of directors is 7.4 years and 7.4 years respectively.

Key information

Dingjun Chu

Chief executive officer

CN¥1.7m

Total compensation

CEO salary percentagen/a
CEO tenure7.4yrs
CEO ownership0.8%
Management average tenure7.4yrs
Board average tenure7.4yrs

Recent management updates

Recent updates


CEO

Dingjun Chu (51 yo)

7.4yrs

Tenure

CN¥1,713,284

Compensation

Mr. Dingjun Chu is General Manager and Director of Aurisco Pharmaceutical Co.,Ltd. since June 01, 2017.


Leadership Team

NamePositionTenureCompensationOwnership
Dingjun Chu
GM & Director7.4yrsCN¥1.71m0.81%
CN¥ 69.7m
Liqin Zhang
Deputy GM & Director of Sales7.4yrsCN¥1.29m0.044%
CN¥ 3.8m
Guoping Wang
Deputy GM & Director7.4yrsCN¥1.75mno data
Fangfang Li
Board Secretary7.4yrsCN¥1.13mno data
Zhenping Zhao
Deputy General Manager6.7yrsCN¥906.76k0.062%
CN¥ 5.3m

7.4yrs

Average Tenure

51yo

Average Age

Experienced Management: 605116's management team is seasoned and experienced (7.4 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Dingjun Chu
GM & Director7.4yrsCN¥1.71m0.81%
CN¥ 69.7m
Guoping Wang
Deputy GM & Director4.5yrsCN¥1.75mno data
Yizhou Chu
Vice Chairman7.4yrsCN¥76.12k31.71%
CN¥ 2.7b
Zhien Peng
Chairman of the Board7.4yrsCN¥1.36m37.81%
CN¥ 3.2b
Peijing Qiu
Director7.4yrsCN¥1.08m2.75%
CN¥ 236.1m
Ping Jin
Chairman of the Supervisory Board7.4yrsno data0.81%
CN¥ 69.7m
Yue Zhou
Supervisor7.4yrsno datano data

7.4yrs

Average Tenure

58yo

Average Age

Experienced Board: 605116's board of directors are considered experienced (7.4 years average tenure).